Bob Valamehr, Ph.D.
About Bob Valamehr, Ph.D.
Chief Research & Development Officer at Fate Therapeutics
Bob Valamehr, Ph.D., serves as the Chief Research & Development Officer at Fate Therapeutics. In this role, he oversees the company’s research and development initiatives. His work at Fate Therapeutics involves leading efforts to discover and develop cutting-edge therapies in the field of cancer immunotherapy and stem cell biology. Valamehr has a significant impact on the company's strategic planning and execution of R&D projects.
Previous Roles at Fate Therapeutics
Before becoming the Chief Research & Development Officer, Bob Valamehr held the positions of Chief Development Officer and Vice President of Cancer Immunotherapy at Fate Therapeutics. In these roles, he was responsible for leading the development programs focused on cancer treatment. His contributions included strategic development, program leadership, and overseeing clinical trial processes for potential therapies.
Scientific Contributions at Amgen, Center for Cell Control, and Broad Stem Cell Research Center
Bob Valamehr has played key scientific roles at Amgen, the Center for Cell Control, and the Broad Stem Cell Research Center. At these institutions, he was heavily involved in pioneering research efforts to understand and manipulate cellular processes. His work contributed to advancements in controlling pluripotency, modulating stem cell fate, and understanding cellular signaling pathways associated with aberrant cellular function.
Academic Background and Education
Bob Valamehr earned his Ph.D. from the Department of Molecular and Medical Pharmacology at UCLA. He also holds an M.B.A. from Pepperdine University and a B.S. in Chemistry and Biochemistry from UCLA. His academic background provided a strong foundation for his work in stem cell biology, oncology, and materials science.
Publications and Patents
Bob Valamehr has co-authored numerous studies and patents related to stem cell biology, oncology, and materials science. His research has contributed valuable knowledge to the scientific community, particularly in the fields of stem cell differentiation and cancer treatment processes. His publications are widely referenced in scientific literature.